4D MOLECULAR THERAPEUTICS, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • November 10th, 2021 • 4D Molecular Therapeutics Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledNovember 10th, 2021 Company Industry JurisdictionThis Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between Fariborz Kamal (“Executive”) and 4D Molecular Therapeutics, Inc. (the “Company”), effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”).